BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15694655)

  • 1. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
    Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
    Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and preliminary evaluation of benzimidazole derivatives as antimicrobial agents.
    Klimesová V; Kocí J; Pour M; Stachel J; Waisser K; Kaustová J
    Eur J Med Chem; 2002 May; 37(5):409-18. PubMed ID: 12008055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly active antimycobacterial derivatives of benzoxazine.
    Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
    Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New benzimidazole derivatives as antimycobacterial agents.
    Klimesová V; Kocí J; Waisser K; Kaustová J
    Farmaco; 2002 Apr; 57(4):259-65. PubMed ID: 11989805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests.
    Rando DG; Doriguetto AC; Tomich de Paula da Silva CH; Ellena J; Sato DN; Leite CQ; Varanda EA; Ferreira EI
    Eur J Med Chem; 2006 Oct; 41(10):1196-200. PubMed ID: 16828526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
    Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
    Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New agents with antimycobacterial activity.
    Marco-Contelles J; Gómez-Sánchez E
    Arch Pharm (Weinheim); 2005 Nov; 338(11):562-3. PubMed ID: 16281303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles.
    Vinsova J; Cermakova K; Tomeckova A; Ceckova M; Jampilek J; Cermak P; Kunes J; Dolezal M; Staud F
    Bioorg Med Chem; 2006 Sep; 14(17):5850-65. PubMed ID: 16784871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antistaphylococcal activity of N-substituted-1H-benzimidazole-sulphonamides.
    Püsküllü MO; Yildiz S; Göker H
    Arch Pharm (Weinheim); 2010 Jan; 343(1):31-9. PubMed ID: 19927309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
    Kocí J; Klimesová V; Waisser K; Kaustová J; Dahse HM; Möllmann U
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3275-8. PubMed ID: 12392731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oriented development of antituberculotics: salicylanilides.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
    Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
    Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
    Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives.
    Klimesová V; Zahajská L; Waisser K; Kaustová J; Möllmann U
    Farmaco; 2004 Apr; 59(4):279-88. PubMed ID: 15081345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimycobacterial activity of pyridylmethylsulfanyl and naphthylmethylsulfanyl derivatives of benzazoles, 1, 2, 4-triazole, and pyridine-2-carbothioamide/-2-carbonitrile.
    Zahajská L; Klimesová V; Kocí J; Waisser K; Kaustová J
    Arch Pharm (Weinheim); 2004 Oct; 337(10):549-55. PubMed ID: 15476287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
    Bergmann KE; Cynamon MH; Welch JT
    J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of substitution on the antimycobacterial activity of 2-(substituted benzyl)sulfanyl benzimidazoles, benzoxazoles, and benzothiazoles--a quantitative structure-activity relationship study.
    Pytela O; Klimešová V
    Chem Pharm Bull (Tokyo); 2011; 59(2):179-84. PubMed ID: 21297296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives.
    Yildiz-Oren I; Yalcin I; Aki-Sener E; Ucarturk N
    Eur J Med Chem; 2004 Mar; 39(3):291-8. PubMed ID: 15051178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives.
    Ansari KF; Lal C
    Eur J Med Chem; 2009 Oct; 44(10):4028-33. PubMed ID: 19482384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.